Evidence map›Paper›PMID 36321123›Full record

ArticleAfrican health sciences2022

Mobile Phone-based Intervention to promote un-interrupted HIV treatment during the COVID-19 pandemic.

Damalie Nakanjako, Eisah Kakyama Mayanja, Agnes Semwanga Rwashana, Fred Semitala, Cordelia Katureebe, Mina Ssali, Martin Muddu, Isaac Ssinabulya

Abstract read
In one paragraph

Article in African health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Damalie NakanjakoDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda.
Eisah Kakyama MayanjaNew Wave Technologies, P.0.Box 24159, Kampala, Uganda.
Agnes Semwanga RwashanaDepartment of Information Systems, College of Computing and Information Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.
Fred SemitalaDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda.
Cordelia KatureebeMinistry of Health, HIV treatment program, Kampala, Uganda.
Mina SsaliMinistry of Health, HIV treatment program, Kampala, Uganda.
Martin MudduMakerere Joint AIDS Program, Kampala, Uganda.
Isaac SsinabulyaDepartment of Medicine, School of Medicine, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Funding

Leveraging existing HIV differentiated service delivery models to screen and treat hypertension in Ugandan persons living with HIV for dual controlK43TW011963 · FIC · INFECTIOUS DISEASES RES COLLABORATION · PI MUDDU, MARTIN · 2021 to 2025
$667k
FIC NIH HHS K43 TW011963
6 · The paper itself

Abstract

Introduction: Keeping HIV-infected adults away from the health care system during the COVID-19 travel restrictions, presents a challenge to HIV treatment adherence. Methods: This study focused on the initial two phases where Phase 1 designed a Makerere College of Health Sciences (MakCHS) Unstructured Supplementary Service Data (USSD)-based application; and Phase 2 piloted patient enrolment onto the application and determined the feasibility of remote follow-up of patients receiving long-term antiretroviral therapy (ART). Results: A off/online user application, MakCHS Health app, was developed. Overall, 112 patients [(66(59%) female] receiving ART at Mulago ISS clinic, Kampala, were enrolled onto the MakCHS Health app. Up to 89 (80%) utilized the app to access medical help. Patients' medical queries included needs for drug refills, missed taking HIV medication, medical illnesses, access to COVID-19 vaccination and other personal needs that required clinicians' attention. Conclusion: Piloting a MakCHS Health application for patient follow-up was feasible and well-received by HIV treatment providers and patients receiving ART. We recommend scale up of the application to enroll all patients receiving long-term treatment for HIV/AIDS, and subsequently expand to. other HIV treatment programs in similar settings.

Indexed as

Cell PhoneCOVID-19HIV InfectionsAdultCOVID-19 VaccinesFemaleHumansMalePandemicsUgandaCOVID-19 VaccinesAntiretroviral therapyChronic HIV treatmentM-Healthpatient follow up

Identifiers

PMID36321123
PMCPMC9590328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.